Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Correlates of protection against SARS-CoV-2 in rhesus macaques
Katherine McMahan et al.
NATURE (2021)
Immune determinants of COVID-19 disease presentation and severity
Petter Brodin
NATURE MEDICINE (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Mads Delbo Larsen et al.
SCIENCE (2021)
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Zijun Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals
Jian Zhang et al.
NATURE MICROBIOLOGY (2021)
Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need
Pengfei Jin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Proinflammatory IgG Fc structures in patients with severe COVID-19
Saborni Chakraborty et al.
NATURE IMMUNOLOGY (2021)
What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review
Shelly Bolotin et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
Bin Lou et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2
Jianzhong Shi et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Yonggang Zhou et al.
NATIONAL SCIENCE REVIEW (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
Andrea Padoan et al.
CLINICA CHIMICA ACTA (2020)
Comprehensive mapping of immune perturbations associated with severe COVID-19
Leticia Kuri-Cervantes et al.
SCIENCE IMMUNOLOGY (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher et al.
CELL (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
Animal models for COVID-19
Cesar Munoz-Fontela et al.
NATURE (2020)
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takehiro Takahashi et al.
NATURE (2020)
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng et al.
NATURE IMMUNOLOGY (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Lisa Miorin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T. Huang et al.
NATURE COMMUNICATIONS (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC
William J. Liu et al.
JOURNAL OF IMMUNOLOGY (2017)
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Jincun Zhao et al.
IMMUNITY (2016)
Induction of mucosal immunity through systemic immunization: Phantom or reality?
Fei Su et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Daniel C. Payne et al.
EMERGING INFECTIOUS DISEASES (2016)
Nomenclature for Immune Correlates of Protection After Vaccination
Stanley A. Plotkin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2010)
Varicella-Zoster Virus-Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine
Adriana Weinberg et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway
Hongliang Wang et al.
CELL RESEARCH (2008)
Correlates of protective immunity in poxvirus infection: where does antibody stand?
Vijay Panchanathan et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function
Vijay Panchanathan et al.
JOURNAL OF VIROLOGY (2006)
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
W Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles
CH Pan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Duration of antiviral immunity after smallpox vaccination
E Hammarlund et al.
NATURE MEDICINE (2003)
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
E Miller et al.
VACCINE (2001)
Share Paper
